Market Research Logo

Brazil Pharmaceuticals and Healthcare Report Q2 2015

Brazil Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Continued regulatory improvements, growing pharmaceutical and healthcare markets, andincreased favour for foreign investment will allow Brazil to maintain its position as the regionaloutperformer in Latin America. However, low affordability and increasing generic drug competition willhamper opportunities for innovative drugmakers as the country continues to develop its economy.

Headline Expenditure Projections

Pharmaceuticals: BRL62.0bn (USD26.3bn) in 2014 to BRL65.3bn (USD25.6bn) in 2015; +5.2% in localcurrency terms and -2.8% in US dollar terms. Forecast in local currency has been maintained from Q115while US dollar growth sees limited development due to depreciating Brazilian Real.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Brazil 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Brazil 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Brazil 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Brazil 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Brazil 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Brazil 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Brazil 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: GDP By Expenditure (Brazil 2012-2019)
Industry Risk Reward Ratings
Americas Risk/Reward Index
Brazil Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Table: Healthcare Resources
Table: Healthcare Activity
Table: Healthcare Personnel
Research & Development
Biotechnology
Clinical Trials
Regulatory Development
Intellectual Property Issues
Counterfeit Drugs
Compulsory Licensing
Pricing Regime
Reimbursement Regime
Protectionist Measures
Competitive Landscape
Table: Top 10 Pharmaceutical Companies In Brazil By Sales In 2013
Innovative Drugmakers
Generic Drugmakers
OTC Sector
Pharmaceutical Distribution Sector
Pharmaceutical Retail Sector
Company Profile
Aché/Biosintética
EMS Sigma
Eurofarma
Medley
Cristália
Sanofi
Pfizer
Merck & Co
Novartis
GlaxoSmithKline
Table: GSK'S Strong Collaborative Efforts In Public-Private Partnerships (Ppps) In Brazil
Roche
Demographic Forecast
Table: Population Headline Indicators (Brazil 1990-2025)
Table: Key Population Ratios (Brazil 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Brazil 1990-2025)
Table: Population By Age Group (Brazil 1990-2025)
Table: Population By Age Group % (Brazil 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report